Literature DB >> 8980595

Chloroquine resistant Plasmodium vivax malaria in India.

V K Dua1, P K Kar, V P Sharma.   

Abstract

In India, 1.2-1.5 million new cases of Plasmodium vivax occur each year. These cases are successfully treated with 600 mg chloroquine (adult dose). We report the results of malaria treatment of a 13-year-old girl from the Indian Oil Corporation (IOC), Mathura, India who contracted P. vivax infection. The infection failed to respond to 2 cycles of standard chloroquine therapy. The concentrations of chloroquine were monitored with high performance liquid chromatography (HPLC). The plasma and whole blood chloroquine concentrations were 260 and 106 micrograms/l respectively, while a 15 micrograms/l plasma concentration is considered lethal to P. vivax. Resistance in P. vivax to chloroquine was found at the IOC, Mathura.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8980595     DOI: 10.1111/j.1365-3156.1996.tb00116.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  41 in total

Review 1.  Chloroquine resistance in Plasmodium vivax.

Authors:  J Kevin Baird
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

2.  Simple Molecular Methods for Early Detection of Chloroquine Drug Resistance in Plasmodium vivax and Plasmodium falciparum.

Authors:  Gurjeet Singh; Raksha Singh; Anant Dattatraya Urhehar
Journal:  J Clin Diagn Res       Date:  2016-07-01

3.  In vitro anti-malarial drug susceptibility of temperate Plasmodium vivax from central China.

Authors:  Feng Lu; Qi Gao; Kesinee Chotivanich; Hui Xia; Jun Cao; Rachanee Udomsangpetch; Liwang Cui; Jetsumon Sattabongkot
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

Review 4.  In silico studies on DARC.

Authors:  Alexandre G de Brevern; Ludovic Autin; Yves Colin; Olivier Bertrand; Catherine Etchebest
Journal:  Infect Disord Drug Targets       Date:  2009-06

5.  Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes.

Authors:  Céline Barnadas; Arsène Ratsimbasoa; Magali Tichit; Christiane Bouchier; Martial Jahevitra; Stéphane Picot; Didier Ménard
Journal:  Antimicrob Agents Chemother       Date:  2008-09-22       Impact factor: 5.191

Review 6.  Malaria in South Asia: prevalence and control.

Authors:  Ashwani Kumar; Laura Chery; Chinmoy Biswas; Nagesh Dubhashi; Prafulla Dutta; Virendra Kumar Dua; Mridula Kacchap; Sanjeeb Kakati; Anar Khandeparkar; Dalip Kour; Satish N Mahajan; Ardhendu Maji; Partha Majumder; Jagadish Mohanta; Pradyumna K Mohapatra; Krishnamoorthy Narayanasamy; Krishnangshu Roy; Jayanthi Shastri; Neena Valecha; Rana Vikash; Reena Wani; John White; Pradipsinh K Rathod
Journal:  Acta Trop       Date:  2012-01-08       Impact factor: 3.112

7.  A cross sectional investigation of malaria epidemiology among seven tea estates in Assam, India.

Authors:  Bipul Rabha; D Goswami; Sunil Dhiman; N G Das; P K Talukdar; M J Nath; Indra Baruah; R K Bhola; Lokendra Singh
Journal:  J Parasit Dis       Date:  2011-09-03

8.  Susceptibility to chloroquine, mefloquine and artemisinin of Plasmodium vivax in northwestern Thailand.

Authors:  Birgit Woitsch; Gunther Wernsdorfer; Kanungnit Congpuong; Chaiporn Rojanawatsirivet; Jeeraphat Sirichaisinthop; Walther H Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

9.  Chloroquine-Primaquine Therapeutic Efficacy, Safety, and Plasma Levels in Patients with Uncomplicated Plasmodium vivax Malaria in a Colombian Pacific Region.

Authors:  Esteban Mesa-Echeverry; Mayra Niebles-Bolívar; Alberto Tobón-Castaño
Journal:  Am J Trop Med Hyg       Date:  2019-01       Impact factor: 2.345

10.  Hidden burden of malaria in Indian women.

Authors:  Vinod P Sharma
Journal:  Malar J       Date:  2009-12-08       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.